HALLE/SAALE, Germany, 6 May 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), will publish its first quarter business update for the period ended 31 March 2015 on Wednesday, May 13, 2015, in the form of an interim management report.

The First Quarter 2015 Business Update will be available for download on the company website (http://www.probiodrug.de/investors/reports-and-presentations/).

For more information, please contact:
Dr Konrad Glund, CEO
Email: contact@probiodrug.de

Hume Brophy
Mary Clark, Supriya Mathur, Hollie Vile
Tel: +44 (0) 203 440 5653
Email: probiodrug@humebrophy.com